Show
Sort by
-
Cohort enrichment strategies for progressive interstitial lung disease in systemic sclerosis From European Scleroderma Trials and Research
-
Racial differences in systemic sclerosis disease presentation : a European Scleroderma Trials and Research group study
-
Tocilizumab in systemic sclerosis : a randomised, double-blind, placebo-controlled, phase 3 trial
-
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual
-
- Journal Article
- A1
- open access
Phenotypes determined by cluster analysis and their survival in the prospective European Scleroderma Trials and Research cohort of patients with systemic sclerosis
-
Brief report: Smoking in systemic sclerosis : a longitudinal European Scleroderma Trials and Research group study
-
Functional disability and its predictors in systemic sclerosis : a study from the DeSScipher project within the EUSTAR group
-
- Journal Article
- A1
- open access
The impact of agent density on scalability in collective systems : noise-induced versus majority-based bistability
-
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study
-
Update of EULAR recommendations for the treatment of systemic sclerosis